Collegium Pharmaceutical (COLL) Return on Invested Capital (2020 - 2026)

Collegium Pharmaceutical's Return on Invested Capital history runs 7 years deep, the most recent figure standing at 0.01% for Q1 2026.

• On a quarterly basis, Return on Invested Capital rose 1.0% year-over-year to 0.01% in Q1 2026; TTM through Mar 2026 was 0.01%, a 1.0% increase from a year earlier, with the FY2025 full-year figure at 0.03%, up 2.0% from the prior year.
• Return on Invested Capital rose to 0.01% in Q1 2026 per COLL's latest filing, from 0.01% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.01% in Q1 2026 and bottomed at 0.0% in Q2 2022.
• The 5-year median for Return on Invested Capital is 0.0% (2024), against an average of 0.0%.
• Biggest YoY gain for Return on Invested Capital was 1 bps in 2022; the steepest drop was 0 bps in 2022.
• Year by year, Return on Invested Capital stood at 0.0% in 2022, then jumped by 452 bps to 0.0% in 2023, then jumped by 68 bps to 0.0% in 2024, then soared by 318 bps to 0.01% in 2025, then grew by 19 bps to 0.01% in 2026.
• Per Business Quant, the three latest COLL Return on Invested Capital figures stand at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025).